Science, Computers & Technology Civil Remedies Health

Pharmaceutical Industry False Claims Act (FCA) FDA Prescription Drugs Healthcare Medical Devices Preliminary Injunctions PHI Biosimilars Data Breach Qui Tam DOJ Generic Drugs Pharmaceutical Patents Settlement BPCIA HHS HIPAA Appeals Hospitals Medicare Amgen Medicaid Patent Infringement Patents Whistleblowers Damages Data Protection Class Action Pharmacies Sandoz v Amgen Affordable Care Act OCR Physicians Anti-Kickback Statute Calculation of Damages Canada First Amendment Health Care Providers Off-Label Promotion OIG Popular Sandoz Amarin Apotex Biologics Commercial Marketing Compliance FDA Approval FDCA Fraud Kickbacks Life Sciences Manufacturers Patent Litigation Punitive Damages Relators SCOTUS Actavis Inc. Antitrust Litigation Bristol-Myers Squibb Civil Monetary Penalty Competition Declaratory Judgments Drug Approvals Electronic Medical Records Eli Lilly First-to-File Free Speech Health Information Technologies Health Insurance HONI Johnson & Johnson Jurisdiction Marketing Negligence Nursing Homes Omnicare Patent Invalidity Patented Medicines Personally Identifiable Information PMNOC Regulations Sealed Records Stark Law State Medical Board Summary Judgment Telemedicine Teva Pharmaceuticals Advertising Anti-Competitive AstraZeneca Attorney Generals CETA Class Certification Clinical Laboratories CMIA CMS Constitutional Challenges Covered Entities Cybersecurity Disgorgement Drug Pricing Enforcement Actions False Statements Final Rules FTC Government Investigations Hatch-Waxman Health Canada In-Person Exam Innovator Liability Inter Partes Review (IPR) Proceeding Irreparable Harm Jury Verdicts Medical Records Medicare Part D Medtronic Mental Health Misbranding Mobile Devices Monopolization Mylan Pharmaceuticals Off-Label Use Orphan Drugs Patent Dance Patented Medicine Prices Review Board (PMPRB) Patient Confidentiality Breaches Pfizer PHRMA Preemption Public Disclosure Rebates Remuneration Section 340B Section 8 Settlement Agreements Sherman Act Standard of Care Standing Transvaginal Mesh Abbott Laboratories AbbVie Abuse of Discretion Abuse of Power Acquisitions Administrative Authority Administrative Remedies Admissible Evidence Ambulance Providers America Invents Act ANDA Anthem Blue Cross Anticompetitive Agreements Antitrust Injuries Antitrust Investigations Antitrust Violations App Developers Apportionment Australia Australian Medical Association Avandia BMW Boston Scientific Brand Name Prescription Drugs Breach of Contract Business Records CA Supreme Court China Chiropractors CIGNA Commercial Speech Commonality Concentra Confidential Business Information (CBI) Consent Order Corrective Actions Cost-Sharing Counterclaims Criminal Prosecution Cross-Appeals Cyber Attacks Data Theft Debt Collection Declaratory Rulings Deductibles Department of Health Department of Health and Human Services DePuy Hip Replacement Design Defects Destruction of Evidence Disclosure Dismissals Dispute Resolution Drug & Alcohol Abuse Duty to Mitigate Duty to Warn Elder Abuse Enablement Inquiries Encryption Estoppel Ethicon EU Evidence Expert Testimony Exports Failure To Warn Fair Work Commission False Billing FCRA Federal Contractors Federal Rules of Civil Procedure FERA FFDCA Financial Conduct Authority (FCA) Fines First Impression Food & Drug Regulations France Frivolous Lawsuits FTC Act Genentech GlaxoSmithKline Hackers Halifax Hospital Halliburton Hart-Scott-Rodino Act Health Insurance Exchanges Healthcare Fraud Hearsay Hearsay Exceptions HIPAA Audits HIPAA Breach HIPAA Omnibus Rule HITECH HRSA Humana Identity Theft India Indictments Infectious Diseases Innovation Invasion of Privacy IP License Janssen Pharmaceuticals Judicial Review Labeling Learned Intermediary Loss Mitigation Lost Profits MACs Malfeasance Managed Care Contracts Mass Tort Litigation Media Medical Foods Medical Malpractice Medicare Advantage MedQuest Merck Motion to Amend Multidistrict Litigation Multinationals Neglect Negligent Misrepresentation New Legislation NIH Notice Provisions Notice Requirements Obviousness Opioid Orange Book Overpayment OxyContin Patent Prosecution Patent Terms Patent Trial and Appeal Board Penalties Pending Legislation Permanent Injunctions Personal Liability Personalized Medicine PHSA Physician Medicare Reimbursements Post-Grant Review Precision Medicine Initiative (PMI) Prescribing Authority Prescription Drug Coverage Pretext Prior Art Proctor & Gamble Product Exclusivity Product Hopping Professional Liability Promise Doctrine Proposed Amendments Proposed Legislation Public Interest QCA Healthplan Radiopharmaceuticals Refill Reminders Reporting Requirements Retaliation Rulemaking Process Safe Harbors SEC Section 5 Securities Litigation Self-Referral Sexual Harassment Shareholder Litigation State Law Claims Stem cells STRONG Patents Act Supervision Supreme Court of Canada Sutter Health Telehealth Theft Trade Agreements TRICARE Unfair Competition Universal Health Services Inc v United States ex rel Escobar USPTO Vaccinations Wells Fargo Wrongful Death WSLA